Wegovy Tablets: What to Know About the New Weight-Loss Pill

The Wegovy tablet has been licensed by the MHRA for weight management in eligible adults. Licensing means the regulator has reviewed evidence on quality, safety and effectiveness for the approved use.

It does not mean that the medicine is suitable for everyone, immediately available through every provider or automatically funded by the NHS. It also does not remove the need for a prescription, clinical assessment or ongoing monitoring.

Wegovy tablets contain semaglutide, a GLP-1 receptor agonist. Semaglutide acts on appetite-regulating pathways and can help people feel fuller, reduce hunger and eat less when used alongside wider weight-management support.

The tablet is a different formulation of semaglutide from the Wegovy injection. It is designed to allow enough of the medicine to be absorbed through the stomach when taken using the correct routine.

In a major clinical trial involving adults without type 2 diabetes, people taking daily oral semaglutide alongside lifestyle support lost substantially more weight on average than those taking placebo.

Published headline results are group averages, not a promise of what one person will lose. Results can be affected by the study population, treatment duration, adherence, dose escalation, lifestyle support and how many participants completed treatment.

The active ingredient is the same, but the doses cannot be compared milligram for milligram because oral absorption is very different from injection.

There has not been one direct head-to-head study proving that one format is better for every patient. Results from separate trials should not be treated as a like-for-like promise of individual weight loss.

For the wider comparison: Mounjaro, Wegovy & Foundayo: Injections vs Tablets Compared

Correct timing matters because food, drink and other medicines can reduce how much semaglutide is absorbed.

What happens if I eat or drink too soon?

Food, larger amounts of water and other oral medicines can reduce semaglutide absorption. This does not necessarily mean one imperfect dose will cause harm, but repeated problems with the routine may make treatment less reliable.

People who drink coffee immediately on waking, eat early, work changing shifts or take time-sensitive morning medicines may need to plan carefully with their clinician or pharmacist.

What if I forget a dose?

Follow the patient information supplied with your medicine and the advice from your prescriber. Do not take extra tablets to compensate unless specifically instructed. A daily missed dose is managed differently from a missed weekly injection.

• people who have a strong fear or dislike of needles;
• people who feel injection technique is a barrier;
• people who prefer a daily tablet routine to a weekly pen;
• people who want a treatment that does not involve injection equipment;
• people whose clinician believes oral semaglutide may be a suitable option.

Interest does not necessarily mean suitability. Someone who dislikes needles may still find a weekly injection simpler than fasting and timing a tablet correctly every morning.

A tablet may be less convenient for someone who:

• already takes several oral medicines first thing in the morning;
• has an unpredictable breakfast or shift-work routine;
• finds it difficult to remember daily medication;
• would struggle to wait before eating, drinking coffee or taking other tablets;
• prefers one planned treatment day each week;
• has previously managed injection treatment confidently and consistently.

For some people, a weekly pen is simpler than a daily fasting routine. The best format is the one that is clinically suitable and can be used correctly over time.

Suitability can depend on medical history, BMI and weight-related health risks, previous treatment, current medicines, pregnancy plans, gastrointestinal health, ability to maintain nutrition and hydration, and whether the routine can be followed consistently.

Your clinician may also need to consider diabetes treatment, kidney or liver health, previous pancreatitis or gallbladder problems, planned surgery or sedation, and whether reduced appetite could make adequate nutrition difficult.

Pregnancy, breastfeeding and plans to conceive must be discussed before treatment. Weight-loss medicines are not used during pregnancy, and a clinician should advise when treatment needs to stop before trying to conceive.

The most common side effects are gastrointestinal, including nausea, diarrhoea, constipation and vomiting. This is not the full side-effect guide.

Read separately: Managing Nausea, Constipation and Other Weight-Loss Treatment Side Effects

A switch may be possible for some people, but it must be planned by a prescriber. Oral and injectable doses are not directly equivalent.

A clinician may consider:

• your current injection dose and when it was last taken;
• how well treatment is working;
• side effects and nutritional intake;
• other medicines and morning dosing routines;
• whether the tablet is available and clinically suitable;
• the correct starting plan and monitoring.

The most common side effects affect the digestive system and can include nausea, diarrhoea, constipation, vomiting, abdominal discomfort and reduced appetite. These are covered in more detail in the separate LIVVE side-effect guide.

Contact your clinical team if side effects make it difficult to eat, drink or take essential medicines, or if you are losing weight much faster than expected.

Tell healthcare professionals that you use semaglutide before surgery, procedures or sedation because delayed stomach emptying may affect clinical planning.

Full practical guidance: Managing Nausea, Constipation and Other Weight-Loss Treatment Side Effects

Interest in new weight-loss treatments can attract illegal sellers, counterfeit products and websites that do not complete an appropriate clinical assessment.

Only obtain prescription weight-management medicine from a regulated UK prescriber and pharmacy. Check that the pharmacy is registered with the General Pharmaceutical Council and that a qualified prescriber reviews your medical information.

• Do not buy tablets advertised through social-media messages or informal marketplaces.
• Do not use medicine supplied without a prescription or eligibility assessment.
• Do not assume packaging or a brand name proves that a product is genuine.
• Do not use Rybelsus or another semaglutide product as a substitute unless prescribed for you.

Wegovy tablets are now available through LIVVE. Treatment remains subject to current stock and individual clinical assessment.

A LIVVE clinician may review:

• eligibility and weight-related health risks;
• medical history and current medicines;
• previous weight-management treatment;
• menopause symptoms and HRT where relevant;
• needle preference and ability to follow the tablet routine;
• side effects, nutrition and hydration;
• whether a tablet, injection or another approach is most appropriate.

Completing an assessment does not guarantee that Wegovy tablets will be prescribed. Your clinician may recommend a different option or decide that prescription treatment is not appropriate.

Starting treatment: What to Expect During the First 12 Weeks of Weight-Loss Treatment

Is there really a Wegovy pill?

Yes. A once-daily semaglutide tablet has been licensed in the UK for weight management in eligible adults. It is a prescription-only medicine and is not suitable for everyone.

Is the Wegovy tablet the same as the injection?

Both contain semaglutide and act on the GLP-1 pathway, but they are different formulations with different dosing schedules and administration instructions. The tablet is taken daily using a fasting routine, while the injection is taken once weekly.

Is the Wegovy tablet the same as Foundayo?

No. Wegovy tablets contain semaglutide, while Foundayo contains orforglipron. Both are once-daily oral GLP-1 treatments, but Wegovy tablets require an overnight fast and a wait of at least 30 minutes before food, drink or other oral medicines, whereas Foundayo can be taken at any time of day without food or water restrictions. Foundayo also has specific advice for people using oral hormonal contraception. A clinician should assess which treatment is appropriate for you; do not switch, combine or substitute them yourself.

Will the tablet replace injections?

Not necessarily. Some people may prefer an oral option, while others may find a weekly injection simpler than a daily fasting routine. Both formats may continue to have a role depending on clinical suitability, preference, tolerance and availability.

Can I switch from injection to tablet?

A switch may sometimes be considered, but it is not a direct dose-for-dose change. A clinician must review timing, previous treatment, side effects, current medicines and the most appropriate plan. Do not switch or overlap treatment without prescriber guidance.

Are Wegovy tablets available through LIVVE?

Yes. Wegovy tablets are now available through LIVVE. Your clinician can discuss the tablet option during your consultation, but prescribing remains subject to clinical suitability and current stock availability.

How much weight could I lose with Wegovy tablets?

Clinical studies report average results across groups rather than a guaranteed result for one person. In a major trial, adults taking daily oral semaglutide alongside lifestyle support lost substantially more weight than those taking placebo. Your response will depend on factors including adherence, dose progression, side effects, nutrition, activity and individual biology.

Can I drink coffee after taking a Wegovy tablet?

You should wait at least 30 minutes after taking the tablet before drinking coffee, eating breakfast, drinking anything else or taking other oral medicines. Taking it with food or drinking too soon can reduce how much semaglutide is absorbed.

What should I do if I miss a Wegovy tablet?

Skip the missed dose and take your usual dose the next day at the normal time. Do not take two tablets together to make up for a missed dose. Follow the patient leaflet and contact your clinician if missed doses become frequent.

Is the Wegovy tablet the same as Rybelsus?

Both contain semaglutide, but they are separately licensed products with different approved uses, strengths and dosing instructions. Rybelsus should not be used as a substitute for Wegovy unless it has been specifically prescribed for you.

Can I take Wegovy tablets with levothyroxine or other morning medicines?

Possibly, but the timing needs reviewing because Wegovy tablets must be taken alone on an empty stomach and followed by a 30-minute wait. Levothyroxine and some other oral medicines also have timing requirements, so ask your prescriber or pharmacist to help you plan a safe routine.

Do Wegovy tablets need to be kept in the fridge?

No special temperature storage is required according to the UK patient leaflet. Keep the tablets in their original packaging to protect them from light and moisture, and store them out of the sight and reach of children.